AURO-CEFTAZIDIME ceftazidime (as pentahydrate) 1g powder for injection vial

Country: Australia

Language: English

Source: Department of Health (Therapeutic Goods Administration)

Active ingredient:

ceftazidime pentahydrate, Quantity: 1175 mg (Equivalent: ceftazidime, Qty 1000 mg)

Available from:

Strides Pharma Science Pty Ltd

INN (International Name):

ceftazidime pentahydrate

Pharmaceutical form:

Injection, powder for

Composition:

Excipient Ingredients: sodium carbonate

Administration route:

Intravenous

Units in package:

5 vials, 1 vial

Prescription type:

(S4) Prescription Only Medicine

Therapeutic indications:

AURO-CEFTAZIDIME is indicated for the treatment of single and mixed infections caused by susceptible aerobic organisms with suspected or documented resistance to other antimicrobials, but not to ceftazidime; as an alternative to aminoglycosides in pseudomonal infection in patients in whom aminoglycoside toxicity is a cause for concern and other antipseudomonal antibiotics cannot be used. . Indications include the following.. Severe infections in general. For example: septicaemia (including neonatal sepsis), bacteraemia; in patients in intensive care units with specific problems, e.g. infected burns.. Respiratory tract. For example: pneumonia, bronchopneumonia, infected pleurisy, infected bronchiectasis and bronchitis.. Severe ear, nose and throat infections. For example: otitis media, mastoiditis.. Urinary tract. For example: acute and chronic pyelonephritis, pyelitis, cystitis, urethritis (bacterial only); infections associated with bladder and renal stones.. Skin and soft tissue. . For example: erysipelas, abscesses, cellulitis, infected burns and wounds, mastitis.. Gastrointestinal and abdominal. . For example: intra-abdominal abscesses, enterocolitis.. Bone and joint. . For example: osteitis, osteomyelitis, septic arthritis, infected bursitis.

Product summary:

Visual Identification: White or cream coloured powder; Container Type: Vial; Container Material: Glass Type I Clear; Container Life Time: 12 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Authorization status:

Registered

Authorization date:

2010-10-19